Lunsumio 30 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung
7680683140021
CH-68314
Konzentrat
Associated product:
LUNSUMIO conc perf 30 mg/30 ml flac 30 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLC
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68314
- Drug name
- Lunsumio, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX25
- Authorization status
- B
- Dispensing category
- A
- First authorization
- 09/02/2023
- Authorization expiration date
- 09/02/2027
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LUNSUMIO conc perf 30 mg/30 ml flac 30 ml
- Description (DE)
- LUNSUMIO Inf Konz 30 mg/30 ml Durchstf 30 ml
- Market launch
- 09/02/2023
- Narcotic (BTM)
- No
Other package sizes (1)
LUNSUMIO conc perf 1 mg/ml flac 1 ml
1 DUR
GTIN: 7680683140014